Dr. med. Armin Atzinger

Department of Nuclear Medicine

FAPI PET/CT Immune-Fibrosis Imaging for New Insights into Rheumatologic Disorders (2023) Schmidkonz C, Atzinger A, Ramming A, Kuwert T Journal article Imaging in inflammatory arthritis: progress towards precision medicine (2023) Minopoulou I, Kleyer A, Yalcin-Mutlu M, Fagni F, Kemenes S, Schmidkonz C, Atzinger A, et al. Journal article, Review article Ability of 18F-FDG Positron Emission Tomography Radiomics and Machine Learning in Predicting KRAS Mutation Status in Therapy-Naive Lung Adenocarcinoma (2023) Zhang R, Shi K, Hohenforst-Schmidt W, Steppert C, Sziklavari Z, Schmidkonz C, Atzinger A, et al. Journal article Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells. (2023) Bergmann C, Müller F, Distler J, Györfi AH, Völkl S, Aigner M, Kretschmann S, et al. Journal article, Letter Clinical Images: Increased bone metabolism in secondary hyperparathyroidism (2023) Valor-Mendez L, Atzinger A, Reis P, Manger B, Schett G Journal article Assessment of myocardial fibrosis in patients with systemic sclerosis using [Ga-68]Ga-FAPI-04-PET-CT (2022) Treutlein C, Distler J, Tascilar K, Chenguiti Fakhouri S, Györfi AH, Atzinger A, Matei AE, et al. Journal article Fibroblast Activation Protein Inhibitor Imaging in Nonmalignant Diseases: A New Perspective for Molecular Imaging (2022) Schmidkonz C, Kuwert T, Atzinger A, Cordes M, Schett G, Ramming A, Götz T Journal article, Review article Fibroblast Activation in Psoriasis Patients Assessed by Ga-68-FAPI-04 PET-CT Is Associated with Progression to Psoriatic Arthritis (2022) Fagni F, Simon D, Kleyer A, Tascilar K, Taubmann J, Bayat S, Minopoulou I, et al. Conference contribution Fibroblast Activation Protein (FAP) PET-CT for Depicting Inflammatory Joint Damage in Patients with Psoriatic Arthritis (2022) Rauber S, Mohammadian H, Schmidkonz C, Atzinger A, Raimondo MG, Labinsky H, Treutlein C, et al. Conference contribution Standardized 18F-FDG PET/CT radiomic features provide information on PD-L1 expression status in treatment-naive patients with non-small cell lung cancer (2022) Zhang R, Hohenforst-Schmidt W, Steppert C, Sziklavari Z, Schmidkonz C, Atzinger A, Kuwert T, et al. Journal article